Rory O’Hanlon

4.7k total citations · 2 hit papers
62 papers, 2.3k citations indexed

About

Rory O’Hanlon is a scholar working on Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging and Surgery. According to data from OpenAlex, Rory O’Hanlon has authored 62 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Cardiology and Cardiovascular Medicine, 21 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Surgery. Recurrent topics in Rory O’Hanlon's work include Cardiomyopathy and Myosin Studies (22 papers), Cardiovascular Effects of Exercise (21 papers) and Cardiac Imaging and Diagnostics (18 papers). Rory O’Hanlon is often cited by papers focused on Cardiomyopathy and Myosin Studies (22 papers), Cardiovascular Effects of Exercise (21 papers) and Cardiac Imaging and Diagnostics (18 papers). Rory O’Hanlon collaborates with scholars based in United Kingdom, Ireland and Qatar. Rory O’Hanlon's co-authors include Sanjay Prasad, Dudley J. Pennell, Kenneth McDonald, Mark Ledwidge, Sanjay Sharma, Mary N. Sheppard, Ricardo Wage, Sy Ha, Chiara Bucciarelli‐Ducci and Agata Grasso and has published in prestigious journals such as JAMA, Circulation and Journal of the American College of Cardiology.

In The Last Decade

Rory O’Hanlon

59 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prognostic Significance of Myocardial Fibrosis in Hypertrophic Cardiomyopathy

2010 601 citations Rory O’Hanlon, Agata Grasso et al. Journal of the American College of Cardiology profile →
Natriuretic Peptide–Based Screening and Collaborative Care for Heart Failure

2013 384 citations Mark Ledwidge, J. Gallagher et al. JAMA profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rory O’Hanlon United Kingdom	20	2.0k	538	234	183	153	62	2.3k
Peter Swoboda United Kingdom	27	1.5k 0.7×	1.1k 2.0×	284 1.2×	145 0.8×	40 0.3×	155	2.0k
William E. Moody United Kingdom	22	1.0k 0.5×	511 0.9×	271 1.2×	296 1.6×	27 0.2×	84	1.8k
Scott Akers United States	21	538 0.3×	358 0.7×	241 1.0×	219 1.2×	26 0.2×	62	1.2k
Eddy Barasch United States	21	1.0k 0.5×	410 0.8×	375 1.6×	299 1.6×	18 0.1×	62	1.5k
Daniel Augustine United Kingdom	16	1.0k 0.5×	356 0.7×	226 1.0×	594 3.2×	29 0.2×	53	1.6k
Ardan M. Saguner Switzerland	31	2.1k 1.0×	173 0.3×	233 1.0×	192 1.0×	17 0.1×	178	2.6k
Rupert Williams United Kingdom	13	837 0.4×	543 1.0×	314 1.3×	166 0.9×	32 0.2×	30	1.2k
Berardo Sarubbi Italy	27	1.8k 0.9×	176 0.3×	356 1.5×	1.0k 5.6×	64 0.4×	183	2.3k
John Dernellis Greece	23	1.6k 0.8×	401 0.7×	448 1.9×	327 1.8×	27 0.2×	34	2.0k
Robert Dalla Pozza Germany	20	703 0.4×	59 0.1×	311 1.3×	211 1.2×	35 0.2×	92	1.4k

Countries citing papers authored by Rory O’Hanlon

Since Specialization

Citations

This map shows the geographic impact of Rory O’Hanlon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rory O’Hanlon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rory O’Hanlon more than expected).

Fields of papers citing papers by Rory O’Hanlon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rory O’Hanlon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rory O’Hanlon. The network helps show where Rory O’Hanlon may publish in the future.

Co-authorship network of co-authors of Rory O’Hanlon

This figure shows the co-authorship network connecting the top 25 collaborators of Rory O’Hanlon. A scholar is included among the top collaborators of Rory O’Hanlon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rory O’Hanlon. Rory O’Hanlon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

O’Hanlon, Rory, et al.. (2021). A COMMON CULPRIT AND AN IRISH DELAY: 5-FLUOROURACIL (5FU) INDUCED TRANSIENT MYOCARDITIS. Journal of the American College of Cardiology. 77(18). 2642–2642.

Bucciarelli‐Ducci, Chiara, Dominique Auger, Carlo Di Mario, et al.. (2016). CMR Guidance for Recanalization of Coronary Chronic Total Occlusion. JACC. Cardiovascular imaging. 9(5). 547–556. 51 indexed citations

Ledwidge, Mark, Eoin O’Connell, J. Gallagher, et al.. (2015). Cost-Effectiveness of Natriuretic Peptide-Based Screening and Collaborative Care: A Report from the STOP-HF (St Vincent’s Screening TO Prevent Heart Failure) Study. European Journal of Heart Failure. 17(7). 672–679. 36 indexed citations

Schnell, Frédéric, Nathan R Riding, Rory O’Hanlon, et al.. (2014). Recognition and Significance of Pathological T-Wave Inversions in Athletes. Circulation. 131(2). 165–173. 68 indexed citations

Bermingham, Margaret, Mary Ryder, Bronagh Travers, et al.. (2014). The St Vincent's Potentially Inappropriate Medicines Study: Development of a Disease-Specific Consensus List and its Evaluation in Ambulatory Heart Failure Care. European Journal of Heart Failure. 16(8). 915–922. 19 indexed citations

Daly, Kieran, Ronan J. Curtin, James O’Neill, et al.. (2014). Heart rate awareness in patients with chronic stable heart failure. A multi-center observational study. International Journal of Cardiology. 177(2). 380–384. 11 indexed citations

James, Stephanie, Dávid Barton, Eoin O’Connell, et al.. (2014). Life expectancy for community-based patients with heart failure from time of diagnosis. International Journal of Cardiology. 178. 268–274. 23 indexed citations

Ledwidge, Mark, J. Gallagher, Carmel Conlon, et al.. (2013). Natriuretic Peptide–Based Screening and Collaborative Care for Heart Failure. JAMA. 310(1). 66–66. 384 indexed citations breakdown →

Collier, Patrick, Chris Watson, Ian Dawkins, et al.. (2012). Progression of Left Atrial Volume Index in a Population at Risk for Heart Failure: A Substudy of the STOP-HF (St Vincent's Screening to Prevent Heart Failure) Trial. European Journal of Heart Failure. 14(9). 957–964. 9 indexed citations

10.

Ledwidge, Mark, Rory O’Hanlon, Bronagh Travers, et al.. (2012). Can Individualized Weight Monitoring using the Heartphone Algorithm Improve Sensitivity for Clinical Deterioration of Heart Failure?. European Journal of Heart Failure. 15(4). 447–455. 28 indexed citations

11.

Murtagh, Gillian, Ian Dawkins, P. R. O’Connell, et al.. (2012). Screening to Prevent Heart Failure (STOP-HF): Expanding the Focus Beyond Asymptomatic Left Ventricular Systolic Dysfunction. European Journal of Heart Failure. 14(5). 480–486. 13 indexed citations

12.

Riding, Nathan R, Sanjay Sharma, François Carré, et al.. (2012). Do big athletes have big hearts? Impact of extreme anthropometry upon cardiac hypertrophy in professional male athletes. British Journal of Sports Medicine. 46(Suppl 1). i90–i97. 13 indexed citations

13.

O’Hanlon, Rory, Agata Grasso, Sy Ha, et al.. (2010). Prognostic Significance of Myocardial Fibrosis in Hypertrophic Cardiomyopathy. Journal of the American College of Cardiology. 56(11). 867–874. 601 indexed citations breakdown →

14.

Whyte, Gregory P., Richard Godfrey, Rory O’Hanlon, et al.. (2009). Acute myocardial infarction in the presence of normal coronaries and the absence of risk factors in a young, lifelong regular exerciser. BMJ Case Reports. 2009. bcr0720080384–bcr0720080384. 6 indexed citations

15.

Keenan, Niall, Justin C. Mason, Alicia M. Maceira, et al.. (2009). Integrated cardiac and vascular assessment in Takayasu arteritis by cardiovascular magnetic resonance. Arthritis & Rheumatism. 60(11). 3501–3509. 50 indexed citations

16.

O’Hanlon, Rory & Dudley J. Pennell. (2009). Cardiovascular Magnetic Resonance in the Evaluation of Hypertrophic and Infiltrative Cardiomyopathies. Heart Failure Clinics. 5(3). 369–387. 10 indexed citations

17.

Whyte, Gregory P., Nigel Stephens, Roxy Senior, et al.. (2008). Differentiation of RVOT-VT and ARVC in an Elite Athlete. Medicine & Science in Sports & Exercise. 40(8). 1357–1361. 12 indexed citations

18.

Alpendurada, Francisco, Rory O’Hanlon, & Sanjay Prasad. (2008). Cardiovascular magnetic resonance of cardiomyopathies. Current Cardiology Reports. 11(1). 61–69. 6 indexed citations

19.

O’Hanlon, Rory, Ravi Assomull, & Sanjay Prasad. (2007). Use of cardiovascular magnetic resonance for diagnosis and management in hypertrophic cardiomyopathy. Current Cardiology Reports. 9(1). 51–56. 19 indexed citations

20.

O’Hanlon, Rory & Donal Reddan. (2005). Treatment of Acute Coronary Syndromes in Patients Who Have Chronic Kidney Disease. Medical Clinics of North America. 89(3). 563–585. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact